Nianzhen Chen
Ulm, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2.
Journal: Journal of virology
Published: August 05, 2026
Pseudovirus-based analysis of host cell entry and vaccine-induced neutralisation of Bundibugyo virus.
Journal: The Lancet. Infectious diseases
Published: July 01, 2026
Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K.
Journal: NPJ vaccines
Published: March 11, 2026
Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2.
Journal: The Lancet. Infectious diseases
Published: September 23, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant.
Journal: Virology
Published: June 20, 2025
Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2.
Journal: The Lancet. Microbe
Published: May 09, 2025
Host cell entry and neutralisation sensitivity of the emerging SARS-CoV-2 variant LP.8.1.
Journal: The Lancet. Infectious diseases
Published: January 28, 2025
Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1.
Journal: Vaccines
Published: September 12, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026